HARP
Closed
Harpoon Therapeutics Inc
23.01
0.00 (0.00%)
Last Update: 11 Mar 2024 23:00:00
Yesterday: 23.01
Day's Range: 22.99 - 23.02
Send
sign up or login to leave a comment!
When Written:
0.75
Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company that develops novel T cell engaging biologics for the treatment of cancer and other diseases. The company's proprietary Tri-specific T cell Activating Construct (TriTAC) platform harnesses the power of the immune system to selectively target and kill cancer cells while sparing healthy cells. Harpoon's lead product candidate, HPN424, is being developed for the treatment of prostate cancer and is currently in Phase 1 clinical trials. The company is also developing multiple other TriTAC product candidates for the treatment of solid tumors and hematologic malignancies. Harpoon Therapeutics was founded in 2015 and is headquartered in South San Francisco, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








